跳至主要内容
临床试验/DRKS00020427
DRKS00020427已完成不适用

Clinical Application of SDL-PDT

MVZ Dermatologisches Zentrum Bonn GmbH0 个研究点目标入组 12 人开始时间: 2020年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Written Informed Consent
  • 2. Men and women, at least 18 years of age
  • 3. Diagnosis actinic keratosis with at least 3 clearly recognizable, separate AK lesions in the face or on the scalp
  • 4. Patient is in the judgement of the Investigator suitable for Ameluz SDL-PDT

排除标准

  • 1. Patient is not able to give informed consent
  • 2. AK study lesions are being treated with drugs at study inclusion
  • 3. Intolerability against one or several ingredients of Ameluz 78 mg/g gel
  • 4. Contraindications and/or warning signals to treatemnt with Ameluz 78 mg/g gel are applicable.
  • 5. Expected non-compliance of the patient

研究者

发起方
MVZ Dermatologisches Zentrum Bonn GmbH

相似试验